Raily Aesthetic Medicine International Holdings Limited (HK:2135) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Raily Aesthetic Medicine International Holdings Limited reported its interim financial results, showing a reduced loss for the first half of 2024 compared to the same period in 2023. Revenue increased from 97.58 million to 117.475 million RMB, while the company’s loss per share decreased from 0.47 cent to 0.32 cent, indicating a modest improvement in financial performance.
For further insights into HK:2135 stock, check out TipRanks’ Stock Analysis page.